CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Study of LUCAR-20S in Patients With R/R NHL
- Status
- TERMINATED
- Phase
- PHASE1
Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL
- Status
- COMPLETED
- Phase
- NA
Lenalidomide Monotherapy in R/R DLBCL
- Status
- COMPLETED
- Phase
- N/A
ctDNA and Metabolites in CSF as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Biomarker Guided Treatment in DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Split-Dose R-CHOP for Older Adults With DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2